• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Abbott could pave new roads in diabetes management with dual sensor on the horizon

June 20, 2025 By Sean Whooley

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes

About three years ago, Abbott (NYSE:ABT) announced that it had a new diabetes-related biowearable under development. The technology — a dual sensor that continuously monitors glucose and ketone levels — already had FDA breakthrough device designation. Abbott said at the time that it was set for pivotal trial use in 2023, with regulatory submissions to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, ADA 2025

Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.

June 20, 2025 By Sean Whooley

Tandem t_slim X2 Abbott FreeStyle Libre 3

Tandem Diabetes Care (Nasdaq:TNDM) announced today that its t:slim X2 system now works with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. This marks the latest pairing of automated insulin delivery (AID) and continuous glucose monitor (CGM) technologies between the companies. They announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Tandem Diabetes Care

Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

June 20, 2025 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to pair their pump system with the Abbott dual glucose-ketone sensor, currently under development. Ypsomed and CamDiab join three other companies set to pair their pumps with the sensor after Abbott recently […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, CamDiab, Ypsomed

PharmaSens, SiBionics collab on all-in-one insulin patch pump

June 19, 2025 By Sean Whooley

PharmaSens Niia Essential insulin patch pump

PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump. Switzerland-based PharmaSens develops the Niia Essential insulin patch pump system. The basal-bolus patch pump combines the ease of an insulin pen with the advantages of a sophisticated pump. The company submitted the pump to the FDA at the end […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: PharmaSens, SiBionics

Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

June 19, 2025 By Sean Whooley

Beta Bionics iLet bionic pancreas with Dexcom G7 and Abbott FreeStyle Libre 3 Plus

Beta Bionics (Nasdaq:BBNX) announced today that it agreed to integrate its iLet bionic pancreas with a future dual sensor from Abbott (NYSE:ABT). The agreement pairs the iLet automated insulin delivery system with the sensor designed to continuously monitor glucose and ketone levels. This marks the third such integration for the Abbott dual sensor. The company […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Beta Bionics

CeQur hits insulin patch milestone, highlights commercial expansion

June 18, 2025 By Sean Whooley

CeQur Simplicity insulin delivery patch (1)

CeQur announced today that it reached the milestone of 10 million mealtime insulin injections replaced with its Simplicity insulin patch. Horw, Switzerland began a pilot commercial launch for the FDA-cleared and CE-marked device in early 2021. In April 2021, the company raised $115 million to support that launch and scale up manufacturing. Since then, it says […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: cequr

Zyno recalls certain infusion pumps due to software issue

June 18, 2025 By Sean Whooley

Zyno Medical infusion pump recall screenshot

The FDA classified a recall of certain Zyno Medical infusion pump systems as the most serious kind as a result of a software issue. This recall involves removing certain devices from use or sale. As the most serious type of recall, it means the device may cause serious injury or death if its use continues. […]

Filed Under: Drug-Device Combinations, Featured, Recalls, Technology Tagged With: Zyno Medical

Ypsomed, CamDiab continue global insulin pump iPhone software rollout

June 18, 2025 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed and CamDiab announced that they continued the launch of the iOS version of their automated insulin delivery app in Europe. The two companies in March began the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms. In combination with the mylife YpsoPump, the offering enables people with type 1 diabetes to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: CamDiab, Ypsomed

Dexcom has a Class I CGM receiver recall

June 17, 2025 By Sean Whooley

Dexcom One+ CGM phone and receiver (1)

The FDA’s recall database today posted notices related to a Class I recall for continuous glucose monitor (CGM) components made by Dexcom (Nasdaq:DXCM). Dexcom’s recalls relate to its Dexcom One and One+ offerings and the G6 and G7 CGMs. The One and One+ systems, which are mainly the company’s commercial CGM offering outside the U.S., feature […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

Medtronic to invest $50M in India Diabetes center

June 17, 2025 By Sean Whooley

Medtronic Diabetes Investment in Pune India

Medtronic (NYSE:MDT) announced that it inaugurated a new Diabetes Global Capability Center in India with a significant investment. The medtech giant said it plans to invest $50 million over five years in the Pune, India location. In a post on LinkedIn, Medtronic said: “We are proud to mark a significant milestone with the inauguration of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 174
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS